Shamim Mannan
Dados Biográficos
| ID | 9066932 |
|---|---|
| NOME | Shamim Mannan |
| PRENOMES | Shamim |
| SOBRENOME | Mannan |
| ASSINATURA | MANNAN S |
| AFILIAÇÕES | Clinton Foundation |
| ORCID | 0000-0002-4530-0694 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 3 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 3 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2020 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2026 |
| ÍNDICE H | 0 |
Strengthening TB care pathways
Tuberculosis (TB) continues to be the leading cause of death from infectious diseases, disproportionately affecting populations in low- and middle-income countries, where diagnostic and financial barriers impede timely care. While alternative treatments may offer symptomatic relief, the cornerstone of TB management remains anti-tubercular therapy (ATT) as recommended by the World Health Organization (WHO). Yet, many individuals with TB-like sympt…
Adverse drug reactions in tuberculosis treatment
Adverse drug reactions (ADRs) remain a major barrier to successful tuberculosis (TB) treatment. They undermine adherence, prolong morbidity, and increase the risk of treatment failures and mortality. Yet, evidence on their incidence, duration, and management across diverse patient groups remains limited. We conducted a mixed-methods study to address this gap, using a representative sample of patients from six states in India. Specifically, we com…
Understanding why at-risk population segments do not seek care for tuberculosis
INTRODUCTION: Delaying care-seeking for tuberculosis (TB) symptoms is a major contributor to mortality, leading to worse outcomes and spread. To reduce delays, it is essential to identify barriers to care-seeking and target populations most at risk of delaying. Previous work identifies barriers only in people within the health system, often long after initial care-seeking. METHODS: We conducted a community-based survey of 84 625 households in Che…
Sem obras proeminentes nesta página.
Understanding why at-risk population segments do not seek care for tuberculosis
INTRODUCTION: Delaying care-seeking for tuberculosis (TB) symptoms is a major contributor to mortality, leading to worse outcomes and spread. To reduce delays, it is essential to identify barriers to care-seeking and target populations most at risk of delaying. Previous work identifies barriers only in people within the health system, often long after initial care-seeking. METHODS: We conducted a community-based survey of 84 625 households in Che…
Adverse drug reactions in tuberculosis treatment
Adverse drug reactions (ADRs) remain a major barrier to successful tuberculosis (TB) treatment. They undermine adherence, prolong morbidity, and increase the risk of treatment failures and mortality. Yet, evidence on their incidence, duration, and management across diverse patient groups remains limited. We conducted a mixed-methods study to address this gap, using a representative sample of patients from six states in India. Specifically, we com…
Strengthening TB care pathways
Tuberculosis (TB) continues to be the leading cause of death from infectious diseases, disproportionately affecting populations in low- and middle-income countries, where diagnostic and financial barriers impede timely care. While alternative treatments may offer symptomatic relief, the cornerstone of TB management remains anti-tubercular therapy (ATT) as recommended by the World Health Organization (WHO). Yet, many individuals with TB-like sympt…
Tuberculosis Research and Epidemiology (3 obras) · Health care (2 obras) · Tuberculosis (2 obras) · Adverse effect (1 obras) · Antibiotic Use and Resistance (1 obras) · Complementary and Alternative Medicine Studies (1 obras) · Cornerstone (1 obras) · Diagnosis and treatment of tuberculosis (1 obras) · Drug reaction (1 obras) · Drug-Induced Adverse Reactions (1 obras)